GO

:   gene ontology

KEGG

:   kyoto encyclopedia of genes and genome

PAH

:   pulmonary arterial hypertension

PASMC

:   pulmonary arterial smooth muscle cell

TF

:   transcription factor

Pulmonary arterial hypertension (PAH) is a chronic progressive disease of pulmonary vasculature characterized by sustained elevation of pulmonary vascular resistance and pulmonary arterial pressure, consequently leading to right heart failure and eventual death [1](#feb412322-bib-0001){ref-type="ref"}. The pathogenesis of PAH is associated with genetic predisposition, inflammation, increase in vascular tone, elevation in pulmonary artery cell proliferation and resistance to apoptosis, and the presence of *in situ* thrombosis [2](#feb412322-bib-0002){ref-type="ref"}, [3](#feb412322-bib-0003){ref-type="ref"}, [4](#feb412322-bib-0004){ref-type="ref"}, [5](#feb412322-bib-0005){ref-type="ref"}. Effect of current treatment on PAH remains poor and available therapies to improve long‐term prognosis are limited [6](#feb412322-bib-0006){ref-type="ref"}, so exploring novel molecular mechanisms and generating therapeutic approaches are urgently needed.MicroRNAs (miRNAs) are small noncoding RNA molecules around 22 nucleotides long that bind the 3′‐untranslated region (UTR) of mRNA to degrade mRNA and therefore to negatively regulate relevant genes expression [7](#feb412322-bib-0007){ref-type="ref"}. miRNAs have the ability to target numerous genes mRNA, therefore potentially controlling a host of genes expression and the activity of multiple signaling pathways [8](#feb412322-bib-0008){ref-type="ref"}, [9](#feb412322-bib-0009){ref-type="ref"}, [10](#feb412322-bib-0010){ref-type="ref"}. Recent studies have shown that reduction in microRNA (miR)‐140‐5p is found in both patients with PAH and monocrotaline‐induced PAH models in rat, which is involved in the development of PAH [11](#feb412322-bib-0011){ref-type="ref"}, [12](#feb412322-bib-0012){ref-type="ref"}. Therefore, it is important to identify comprehensive downstream targets of miR‐140‐5p with bioinformatics analysis in PAH, and this might provide some critical information for the development and treatment of PAH. In this study, downstream target genes regulated by miR‐140‐5p and upstream transcription factors (TFs) regulating miR‐140‐5p expression were predicted, and the downstream target genes were analyzed for gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway. Next, the upstream TFs and downstream targets of miR‐140‐5p were determined according to the TF--miRNA--mRNA network. Finally, the direct downstream targets and relevant signaling pathways regulated by miR‐140‐5p were obtained in published literature and were compared with the predicted results of this study.

Materials and methods {#feb412322-sec-0002}
=====================

Mature sequences of miR‐140‐5p in various species {#feb412322-sec-0003}
-------------------------------------------------

Mature sequences of miR‐140‐5p in various species were obtained in the miRBase database (<http://mirbase.org/index.shtml>).

Target gene prediction of miR‐140‐5p {#feb412322-sec-0004}
------------------------------------

Identification of target genes is critical for characterizing the functions of miRNAs. In this study, miRanda (<http://www.microrna.org/>), TargetScan (<http://www.targetscan.org/>), RNAhybrid (<https://bibiserv.cebitec.uni-bielefeld.de/rnahybrid/submission.html>), and miRDB (<http://www.mirdb.org/>) databases were used to predict the target genes of miR‐140‐5p. To make our predicted target genes more convincible, only the target genes predicted by at least three databases were selected for further analyses.

Database‐based GO and KEGG pathway enrichment analysis {#feb412322-sec-0005}
------------------------------------------------------

Target mRNA of miR‐140‐5p supported by at least three databases were used for GO analysis to predict gene functions. Integration Discovery (DAVID) software, version 6.7 (<http://david.abcC.ncifcrf.gov>), was used to perform GO analysis to identify biological processes, cellular components, and molecular functions of these target genes. At the same time, the probable signaling pathways in which these target genes were enriched were analyzed by KEGG database (<http://www.genome.jp/kegg/>). The *P*‐value \<0.05 was considered significant.

Upstream TFs prediction of miR‐140‐5p {#feb412322-sec-0006}
-------------------------------------

Human miR‐140‐5p precursor was obtained in the miRBase database and its 5000 bp upstream was defined as the miR‐140‐5p promoter. The TFs of miR‐140‐5p were predicted using MOODS‐python software (version 1.9.3) in JASPAR database (<http://jaspar.binf.ku.dk/>), which includes various vertebrate TFs. The *P*‐value \<0.0001 was considered significant.

Construction of the network for TF--miR‐140‐5p--mRNA {#feb412322-sec-0007}
----------------------------------------------------

By merging the regulatory relationships between TFs and miR‐140‐5p, miR‐140‐5p and target genes, genes and genes (TF→miRNA, miRNA→gene and gene→gene), we constructed a comprehensive TF--miR‐140‐5p--mRNA regulatory network using Gephi software (release 0.8.1‐β, <http://gephi.github.io/>).

Screening target genes and signaling pathways inhibited by miR‐140‐5p in published studies {#feb412322-sec-0008}
------------------------------------------------------------------------------------------

To obtain downstream target genes and signaling pathways modulated by miR‐140‐5p in published studies, a comprehensive electronic search of Web of Science and PubMed databases was performed until April 20, 2017. The keyword 'miR‐140‐5p' in the titles or abstracts was used, and then, studies exploring the targets of miR‐140‐5p were collected.

Results {#feb412322-sec-0009}
=======

Mature sequences of miR‐140‐5p in various species {#feb412322-sec-0010}
-------------------------------------------------

Mature sequences of miR‐140‐5p in various species were obtained in the miRBase database. The pre‐miR‐140‐5p was located at position 69933081 \~ 69933180 of chromosome 16, and the gene ID of human miR‐140‐5p was MIMAT0000431. As shown in Table [1](#feb412322-tbl-0001){ref-type="table-wrap"}, mature sequences of miR‐140‐5p were highly conserved in various species and human miR‐140‐5p was chosen for further analyses.

###### 

Mature sequences of miR‐140‐5p in various species

  ID             Mature name      Sequence
  -------------- ---------------- --------------------------
  MIMAT0000151   mmu‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0000431   hsa‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0000573   rno‐miR‐140‐5p   `CAGUGGUUUUACCCUAUGGUAG`
  MIMAT0001159   gga‐miR‐140‐5p   AGUGGUUUUACCCUAUGGUAG
  MIMAT0001836   dre‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0002143   ssc‐miR‐140‐5p   AGUGGUUUUACCCUAUGGUAG
  MIMAT0006812   oan‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGU
  MIMAT0006197   mml‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0012745   mdo‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0012926   eca‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0014557   tgu‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0015763   ppy‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0021765   aca‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGU
  MIMAT0022552   ola‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0023767   cgr‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0025434   pol‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0026220   ccr‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0032359   ssa‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0035960   chi‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
  MIMAT0036560   tch‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUA
  MIMAT0036719   oha‐miR‐140‐5p   CAGUGGUUUUACCCUAUGGUAG
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Prediction of target genes for miR‐140‐5p {#feb412322-sec-0011}
-----------------------------------------

As shown in Fig. [1](#feb412322-fig-0001){ref-type="fig"}, the number of predicted target genes of miR‐140‐5p in miRanda, TargetScan, RNAhybrid, and miRDB databases was 2370, 428, 1017, and 262, respectively. There were 482 target genes supported by at least two databases, 123 target genes predicted by at least three databases and five target genes supported by all four databases. The target genes of miR‐140‐5p predicted by at least three databases are listed in Table [2](#feb412322-tbl-0002){ref-type="table-wrap"} and were used for further analyses.

![The number of predicted target genes of miR‐140‐5p.](FEB4-7-1880-g001){#feb412322-fig-0001}

###### 

The target genes of miR‐140‐5p predicted by at least three databases

  ---------- --------- ---------- ------------- ---------- ---------
  ABCA1      ACSL6     ADAM10     ADAMTS5       ADCY6      ANKFY1
  ANKIB1     AP2B1     BACH1      BAZ2B         BCL9       BMP2
  C1R        CADM3     CAND1      CAPN1         CCNYL1     CELF1
  CORO2A     CREB      CTCF       CYTH2         DNM3       DOK4
  DPP10      DPYSL2    EGR2       EIF4G2        ELAVL2     ENTPD5
  EPB41L2    ERC2      FAM175B    FBN1          FCHO2      FES
  FGF9       FLRT2     FOXP2      FYCO1         GNG5       GIT1
  HAND2      HDAC4     HDAC7      HDGFRP3       HNRNPH3    HS2ST1
  HSPA13     IGSF3     IPO7       JAG1          KAT2B      KBTBD2
  KIF1B      KLF6      KLF9       KLK10         LAMC1      LHFPL2
  LMNB1      LPHN2     LRAT       LRP4          LSM14B     LYSMD3
  MARK1      MED13     MMD        MYCBP2        MYO10      NAA20
  NAALADL2   NCKAP1    NCOA1      NCSTN         NFE2L2     NLK
  NPL        NUCKS1    OSBPL6     PPPICC        PAFAH1B2   PDGFRA
  PPTC7      PDE7A     PPP1R12A   PALM2‐AKAP2   RBM39      RFX7
  RNF19A     RALA      RAB10      SEPT2         STRADB     SYS1
  SLAIN1     SAMD4     SMOC2      SNX2          SRCAP      SHROOM3
  SIAH1      SLC30A5   SLC38A2    TTYH3 ST5     TLR4       TTK
  TJP1       TSSK2     TSPAN12    TSC22D2       TTYH2      TGFBR1
  UBR5       UBR5      VEZF1      VEGFA         WNT1       WDFY3
  YOD1       ZBTB10    ZNF800                              
  ---------- --------- ---------- ------------- ---------- ---------
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GO enrichment analysis for predicted target genes of miR‐140‐5p {#feb412322-sec-0012}
---------------------------------------------------------------

GO enrichment analysis was conducted for the target genes of miR‐140‐5p predicted by at least three databases. As shown in Table [3](#feb412322-tbl-0003){ref-type="table-wrap"}, the target genes of miR‐140‐5p were mainly located in basement membrane (*P *\<* *0.05) and participated in the molecular functions of protein binding, activating transcription factor binding, ion binding, lipid binding, and so on (*P *\<* *0.05). In addition, the target genes of miR‐140‐5p were involved in various biological processes, including biological regulation, metabolic process, cell communication, signal transduction, response to chemical stimulus, stem cell proliferation, cell surface receptor signaling pathway (*P *\<* *0.05). Fig. [2](#feb412322-fig-0002){ref-type="fig"} presents the number of target genes corresponding to each GO term.

###### 

Gene ontology (GO) analysis for predicted target genes of miR‐140‐5p

  ---------------------- ----------------------------------------- ----------- ---------------------------------------------------------------------------
  ID                     Term                                      *P*‐value   Genes annotated to the term
  Biological processes                                                         
  GO:0050794             Regulation of cellular process            5.39E‐06    VEGFA\| FGF9\| PPP1CC\|Pin1\|HDAC7\|PDGFRA\|TGFBR1\|ADAM10...
  GO:0050789             Regulation of biological process          9.05E‐06    FGF9\|BMP2\|LAMC1\|NUMBL\|PDGFRA\|PPP1CC\|\|ADAM10\|TLR4\|TGFBR1...
  GO:0007154             Cell communication                        5.69E‐05    WNT1\|PPP1CC\|PDGFRA\|TLR4\|HDAC7\|ADAM10\| BMP2\|TGFBR1...
  GO:0023052             Signaling                                 6.14E‐05    PDGFRA\|PPP1CC\|FGF9\|WNT1\|TGFBR1\|BMP2\|ADAM10\|JAG1\|TLR4...
  GO:0044763             Single‐organism cellular process          8.73E‐05    VEGFA\|FGF9\|LAMC1\|BMP2\|TLR4\|WNT1\|TGFBR1\|PDGFRA\|PPP1CC...
  GO:0065007             Biological regulation                     9.89E‐05    VEGFA\|BMP2\|TLR4\|CREB\|PPP1CC\|PDGFRA\|ADAM10\|TGFBR1...
  GO:0007165             Signal transduction                       0.00011     PPP1CC\|PDGFRA\|WNT1\|TGFBR1\|FGF9\|VEGFA\|NCSTN\|TLR4\|ADAM10...
  GO:0042221             Response to chemical stimulus             0.00048     NUMBL\|PPP1CC\|PDGFRA\|VEGFA\|LAMC1\|TGFBR1\|FGF9\|BMP2\|ADAM10\|TLR4...
  GO:0072089             Stem cell proliferation                   0.00087     ACSL6\|NUMBL\|RAB10\|HAND2\|WNT1\|BMP2...
  GO:0007166             Cell surface receptor signaling pathway   0.00370     TLR4\|WNT1\|BMP2\|ADAM10\|NCSTN\|JAG1\|PPP1CC\|PDGFRA\|FGF9...
  GO:0050896             Response to stimulus                      0.01555     PPP1CC\|PDGFRA\|WNT1\|CREB\|TGFBR1\|VEGFA\|\|FGF9\|BMP2\|ADAM10\|TLR4...
  GO:0019538             Protein metabolic process                 0.02054     CREB\|PPP1CC\|PDGFRA\|NUMBL\|TLR4\|ADAM10\|BMP2\|KAT2B\|NCSTN\| TGFBR1...
  GO:0006464             Cellular protein modification process     0.03073     HDAC4\|CREB\|ADAM10\|TLR4\|TGFBR1\|PPP1CC\|PDGFRA...
  Molecular functions                                                          
  GO:0005515             Protein binding                           2.53E‐07    TLR4\|ADAM10\|PDGFRA\|WNT1\|HDAC7\|VEGFA\|CREB\|PPP1CC\|TGFBR1\|FGF9...
  GO:0005488             Binding                                   0.00048     HDAC7\|JAG\|LMNB1\|PDGFRA\|ADAM10\| TLR4\|FGF9\|KAT2B\|TGFBR1...
  GO:0033613             Activating transcription factor binding   0.00320     EGR2\|NFE2L2\|HDAC4\|HDAC7\|HAND2...
  GO:0043167             Ion binding                               0.00724     VEGFA\|PPP1CC\|ADAM10\|PDGFRA\|TGFBR1\|HDAC4\|FGF9\|HDAC7...
  GO:0008289             Lipid binding                             0.04471     LAMC1\|OSBPL6\|FES\|DNM3\|MYO10\|TLR4...
  Cellular components                                                          
  GO:0005604             Basement membrane                         0.04119     FGF9\|PDGFRA\|TLR4\|VEGFA\|SMOC2...
  ---------------------- ----------------------------------------- ----------- ---------------------------------------------------------------------------
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![Gene ontology (GO) enrichment analysis for predicted target genes of miR‐140‐5p.](FEB4-7-1880-g002){#feb412322-fig-0002}

KEGG pathway analysis for predicted target genes of miR‐140‐5p {#feb412322-sec-0013}
--------------------------------------------------------------

Enriched signaling pathways for the target genes of miR‐140‐5p identified by KEGG pathway analysis were ranked according to the *P*‐values. As shown in Table [4](#feb412322-tbl-0004){ref-type="table-wrap"}, the top rankings were related to Notch, cancer‐associated pathway, TGF‐beta, PI3K/Akt, HTLV infection, Hippo, HIF‐1, alcoholism signaling pathways, and so on (*P *\<* *0.05); among them, Notch, TGF‐beta, PI3K/Akt, and Hippo signaling pathways were well known to be associated with the pathogenesis of PAH. Fig. [3](#feb412322-fig-0003){ref-type="fig"} presents the rich factor, Q value, and gene number corresponding to each pathway term.

###### 

Kyoto Encyclopedia of Genes and Genome (KEGG) pathway analysis for predicted target genes of miR‐140‐5p

  Term                                                         ID         Sample number   Background number   *P*‐value   Genes
  ------------------------------------------------------------ ---------- --------------- ------------------- ----------- --------------------------------------------------------
  Notch signaling pathway                                      hsa04330   4               52                  0.006408    JAG1\|ADAM10\|KAT2B\|NCSTN
  Pathways in cancer                                           hsa05200   9               337                 0.016384    FGF9\|TGFBR1\|VEGFA\|SLC2A1\|WNT1\|BMP2\|PDGFRA\|LAMC1
  Endocrine and other factor‐regulated calcium reabsorption    hsa04961   3               48                  0.022347    AP2B1\|ADCY6\|DNM3
  HTLV‐I infection                                             hsa05166   7               268                 0.031935    TGFBR1\|KAT2B\|SLC2A1\|EGR2\|WNT1\|PDGFRA\|ADCY6
  Regulation of actin cytoskeleton                             hsa04810   6               221                 0.031935    PPP1R12A\|NCKAP1\|FGF9\|GIT1\|PDGFRA\|PPP1CC
  Pancreatic cancer                                            hsa05212   3               66                  0.031935    RALA\|TGFBR1\|VEGFA
  Epithelial cell signaling in Helicobacter pylori infection   hsa05120   3               66                  0.031935    TJP1\|GIT1\|ADAM10
  Proteoglycans in cancer                                      hsa05205   6               231                 0.033735    PPP1R12A\|FGF9\|VEGFA\|WNT1\|TLR4\|PPP1CC
  Adherence junction                                           hsa04520   3               74                  0.037848    NLK\|TJP1\|TGFBR1
  Alcoholism                                                   hsa05034   5               183                 0.038681    HDAC7\|HDAC4\|CREB3L1\|GNG5\|PPP1CC
  PI3K‐Akt signaling pathway                                   hsa04151   7               358                 0.045545    FGF9\|VEGFA\|PDGFRA\|LAMC1\|TLR4\|CREB\|GNG5
  Focal adhesion                                               hsa04510   5               214                 0.045545    PPP1R12A\|VEGFA\|PDGFRA\|LAMC1\|PPP1CC
  Endocytosis                                                  hsa04144   5               212                 0.045545    AP2B1\|TGFBR1\|GIT1\|PDGFRA\|DNM3
  Viral carcinogenesis                                         hsa05203   5               213                 0.045545    HDAC7\|HDAC4\|KAT2B\|EGR2\|CREB3L1
  Hepatitis B                                                  hsa05161   4               151                 0.045545    TGFBR1\|EGR2\|TLR4\|CREB3L1
  Insulin secretion                                            hsa04911   3               92                  0.045545    SLC2A1\|CREB3L1\|ADCY6
  GABAergic synapse                                            hsa04727   3               89                  0.045545    SLC38A2\|GNG5\|ADCY6
  TGF‐beta signaling pathway                                   hsa04350   3               83                  0.045545    TGFBR1\|SMAD4\|BMP2
  Gap junction                                                 hsa04540   3               96                  0.045545    TJP1\|PDGFRA\|ADCY6
  Hippo signaling pathway                                      hsa04390   4               156                 0.045565    TGFBR1\|WNT1\|BMP2\|PPP1CC
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![Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for predicted target genes of miR‐140‐5p.](FEB4-7-1880-g003){#feb412322-fig-0003}

Prediction of upstream TFs for miR‐140‐5p and construction of TF--miR‐140‐5p--mRNA network {#feb412322-sec-0014}
------------------------------------------------------------------------------------------

The number of predicted TFs for miR‐140‐5p with *P*‐value \<0.0001 was 393. To reduce false‐positive results, TFs with a quality score (Q‐score) less than 10 were filtered. As shown in Table [5](#feb412322-tbl-0005){ref-type="table-wrap"}, the remaining TFs, including PAX5, FOXI1, IRF1, FOSL1, RUNX2, were chosen for further analyses. Finally, by merging the regulatory relationships between TFs and miR‐140‐5p, miR‐140‐5p and target genes, as well as genes and genes, we built a comprehensive TF--miR‐140‐5p--mRNA regulatory network, as shown in Fig. [4](#feb412322-fig-0004){ref-type="fig"}.

###### 

Prediction of transcription factors and binding sites of miR‐140‐5p

  Model ID   Model name   Hit position   Strand   Score     Predicted site sequence
  ---------- ------------ -------------- -------- --------- -------------------------
  MA0014.2   PAX5         95             −        10.5663   gtctcactctgttgcccat
  MA0014.2   PAX5         3874           −        11.6915   gtcttgctctgttgcccag
  MA0025.1   NFIL3        722            −        10.0393   TTCTTACATAA
  MA0035.3   Gata1        3391           −        10.0718   acagataaaaa
  MA0036.2   GATA2        3391           −        10.4087   acagataaaaattt
  MA0041.1   Foxd3        4529           \+       10.4011   ttttgtttgttt
  MA0042.1   FOXI1        984            \+       11.5926   GGATGTTTGTTT
  MA0042.1   FOXI1        4529           \+       10.3990   ttttgtttgttt
  MA0046.1   HNF1A        4949           \+       10.3282   agttaataatttta
  MA0050.2   IRF1         3825           \+       11.0065   tttttctttttcttttctttc
  MA0050.2   IRF1         3840           \+       12.4803   tctttctttcttttttttttt
  MA0050.2   IRF1         3844           \+       10.0776   tctttcttttttttttttttt
  MA0062.2   GABPA        1506           \+       10.0387   ccggaagtcga
  MA0073.1   RREB1        1164           −        10.9028   TTTTGGTTGTTGTTTTGTTT
  MA0073.1   RREB1        3734           \+       10.2056   caacaaaacaaaacaaaaca
  MA0471.1   E2F6         143            −        10.6410   tcttcccgcct
  MA0477.1   FOSL1        4238           −        11.2229   cctgagtcacc
  MA0478.1   FOSL2        4239           −        10.3145   ctgagtcacct
  MA0481.1   FOXP1        3756           \+       10.2195   acaaaaaaaacacaa
  MA0481.1   FOXP1        4018           −        10.3465   ttttgtttttttagt
  MA0490.1   JUNB         4239           −        10.6046   ctgagtcacct
  MA0491.1   JUND         2362           \+       10.0256   GAAAATGATATCACA
  MA0493.1   Klf1         4812           \+       10.548    caccacaccca
  MA0511.1   RUNX2        3813           \+       11.453    tgtgtatgtggtttt
  MA0515.1   Sox6         3772           −        10.2529   gaaacaatgg
  MA0595.1   SREBF1       2000           −        10.1772   gtggcgtgat
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![Regulatory network of TF--miR‐140‐5p--mRNA.](FEB4-7-1880-g004){#feb412322-fig-0004}

Screening target genes and signaling pathways modulated by miR‐140‐5p in published studies {#feb412322-sec-0015}
------------------------------------------------------------------------------------------

A comprehensive electronic search of Web of Science and PubMed databases was performed until April 20, 2017, to obtain target genes and signaling pathways modulated by miR‐140‐5p in published studies. Finally, a total of 26 papers including 23 target genes and seven signaling pathways inhibited by miR‐140‐5p were obtained; most of them focus on the functions of miR‐140‐5p suppressing tumor growth, migration, and invasion in various tumor tissues and cells. Two recent studies have found that SMURF1 and Dumt1 are direct target genes of miR‐140‐5p in pulmonary arterial smooth muscle cells (PASMCs) and are involved in the pathogenesis of PAH. The details are shown in Table [6](#feb412322-tbl-0006){ref-type="table-wrap"}.

###### 

Target genes and signaling pathways modulated by miR‐140‐5p in published studies. NA, not available; HCC, hepatocellular carcinoma; T‐ALL, T‐cell acute lymphoblastic leukemia; Th1, T helper type 1; HSCC, hypopharyngeal squamous cell carcinoma; EPCs, endothelial progenitor cells; PH, pulmonary hypertension; HUVECs, human umbilical vein endothelial cells; BTC, biliary tract cancer; TSPCs, tendon stem/progenitor cells; LLC, Lewis lung cancer cells; MSCs, mesenchymal stem cells; TSCC, tongue squamous cell carcinoma

  Author (Year)    Target genes           Inhibited pathways                Associated functions                                         Cell or tissue types
  ---------------- ---------------------- --------------------------------- ------------------------------------------------------------ ----------------------------------------
  Hu (2017)        VEGFA                  NA                                Inhibit cell proliferation and invasion, promote apoptosis   Glioma tissues and cells
  Meng (2017)      HMGN5                  NA                                Decrease cell resistance to chemotherapy                     Osteosarcoma tissues and cells
  Yan (2017)       Pin1                   Pin1‐dependent cancer pathway     Suppress tumor growth                                        HCC tissues and cells
  Correia (2016)   TAL1                   NA                                Suppress tumor growth                                        T‐ALL cells
  Guan (2016)      STAT1                  NA                                Suppress Th1 cell differentiation                            Th1 cells
  Jing (2016)      ADAM10                 Notch1 signaling pathway          Suppress tumor migration and invasion                        HSCC tissues and cells
  Liu (2016)       HDAC7                  NA                                Protect EPCs                                                 EPCs
  Lv (2016)        Slug                   NA                                Inhibit cell migration and invasion                          HCC tissues
  Rothman (2016)   SMURF1                 BMP signaling pathway             Inhibit cell proliferation, migration, and PH development    PASMCs, rat PH models
  Su (2016)        IGF2BP1                NA                                Decrease cell proliferation, migration, and invasion         Cervical cancer cells and tissues
  SUN (2016)       VEGFA                  NA                                Decrease cell proliferation, migration, and tube formation   HUVECs
  Wei (2016)       IP3k2                  IP3 signaling pathway             Promote chemotherapy‐induced autophagy                       Human osteosarcoma cells
  Yu (2016)        Septin 2               NA                                Suppress cell proliferation and colony formation             BTC tissues and cells
  Zhang (2016)     Dnmt1                  NA                                Inhibit cell proliferation, promote cell apoptosis           Human PH tissues, human PASMCs
  Barter (2015)    FZD6                   Wnt signaling pathway             Promote chondrogenic differentiation                         Mesenchymal stem cells
  Chen (2015)      Pin1                   NA                                Promote cell senescence                                      TSPCs
  Lan (2015)       PDGFRA                 NA                                Inhibit cancer growth                                        Human ovarian cancer tissues and cells
  Zhai (2015)      Smad2                  TGF‐β signaling pathway           Decrease cell invasion and proliferation                     Colorectal cancer stem cells
  Zhang (2015)     VEGFA                  NA                                Inhibit tumor progression                                    Colorectal cancer tissues and cells
  Zhang (2015)     TGFBR1                 TGF‐β signaling pathway           Regulate adipocyte differentiation                           Bone marrow stromal cells
  Li (2014)        MMD                    ERK signaling pathway             Inhibit cell proliferation                                   LLCs
  Hwang (2014)     BMP2                   BMP signaling pathway             Suppress osteogenesis                                        Human MSCs
  Karlsen (2014)   RALA                   NA                                Stimulate chondrogenesis                                     MSCs
  Yang (2014)      ADAM10, LAMC1, HDAC7   NA                                Suppress migration and invasion                              TSCC tissues and cells
  Shi (2013)       FoxP2                  NA                                Impair dendritic development and vocal learning              Zebra finch brain tissues
  Yang (2013)      TGFBR1, FGF9           TGF‐β and ERK signaling pathway   Suppress cell proliferation and tumor metastasis             HCC tissues and cells

John Wiley & Sons, Ltd

Discussion {#feb412322-sec-0016}
==========

Pulmonary arterial hypertension is a chronic life‐threatening condition requiring long‐term management [13](#feb412322-bib-0013){ref-type="ref"}, and its available therapies are limited [6](#feb412322-bib-0006){ref-type="ref"}. There is a clear and urgent need for new therapeutic options based on deeply exploring the pathogenesis of PAH. Previous studies have indicated that miR‐140‐5p is dramatically downregulated, which in turn causes the development of a variety of cancers by the loss of suppressing tumor cell migration and growth [14](#feb412322-bib-0014){ref-type="ref"}, [15](#feb412322-bib-0015){ref-type="ref"}, [16](#feb412322-bib-0016){ref-type="ref"}, [17](#feb412322-bib-0017){ref-type="ref"}. miR‐140‐5p has been recently found to be reduced in both PAH patients and MCT‐induced PAH models in rat [11](#feb412322-bib-0011){ref-type="ref"}, [12](#feb412322-bib-0012){ref-type="ref"}. However, the downstream targets regulated by miR‐140‐5p contributing to the development of PAH remain largely unknown.

In this study, we found that the target genes of miR‐140‐5p were enriched in many biological processes, such as biological regulation, metabolic process, cell communication, signal transduction, response to chemical stimulus, stem cell proliferation, cell surface receptor signaling pathway. In KEGG pathway analysis, the target genes of miR‐140‐5p were mainly located in Notch, TGF‐beta, PI3K/Akt, and Hippo signaling pathways. According to the TF--miRNA--mRNA network, the important genes potentially regulated by miR‐140‐5p included PPI, TGF‐betaR1, smad4, JAG1, ADAM10, FGF9, PDGFRA, VEGFA, TLR4, LAMC1, CREB, and the upstream TFs, which might regulate miR‐140‐5p expression including TAX5, FOXI, IRF1, GATA6, RUNX2. After thoroughly reviewing published literature, we found that 23 target genes and seven signaling pathways were truly inhibited by miR‐140‐5p in various tissues or cells; most of these downstream targets were in accordance with our present prediction.

Several studies have shown that activation of Notch3 pathway is involved in the pathogenesis of PAH [18](#feb412322-bib-0018){ref-type="ref"}, [19](#feb412322-bib-0019){ref-type="ref"}. We have previously shown that activation of Notch3 promotes PASMC proliferation and inhibition of Notch3 pathway prevents monocrotaline‐induced development of PAH in rat [20](#feb412322-bib-0020){ref-type="ref"}, [21](#feb412322-bib-0021){ref-type="ref"}. JAG1 and ADAM10 are indispensable components of Notch signaling pathway, which were predicted as downstream targets of miR‐140‐5p in our analysis, suggesting that lack of miR‐140‐5p might promote the development of PAH by upregulation of JAG1 and ADAM10 genes and therefore activation of Notch3 cascade. In addition, activation of TGF‐beta1/Smad4 signaling promotes a proliferative PASMC phenotype and induces PAH in rat [22](#feb412322-bib-0022){ref-type="ref"}, [23](#feb412322-bib-0023){ref-type="ref"}. We found that TGF‐betaR1 and smad4 were possible downstream targets of miR‐140‐5p, reduction in miR‐140‐5p in PAH might stimulate TGF‐beta1/Smad4 pathway by upregulating TGF‐betaR1 and smad4. Previous studies have demonstrated that PDGF, TLR4, VEGFA, and FGF contribute to the pathogenesis of PAH via activating various signaling pathways, especially PI3K/Akt cascade [24](#feb412322-bib-0024){ref-type="ref"}, [25](#feb412322-bib-0025){ref-type="ref"}, [26](#feb412322-bib-0026){ref-type="ref"}, [27](#feb412322-bib-0027){ref-type="ref"}, [28](#feb412322-bib-0028){ref-type="ref"}. CREB, an important transcription factor lying downstream of PI3K/Akt pathway, mediates the partial functions of PI3K/Akt [29](#feb412322-bib-0029){ref-type="ref"}. In our analysis, PDGF, TLR4, VEGFA, FGF, and CREB were positively predicted as downstream targets of miR‐140‐5p, implying that miR‐140‐5p negatively regulates the functions of PI3K/Akt cascade by targeting FGF9, PDGFRA, VEGFA, TLR4, or CREB gene. Recent studies have also shown that Hippo signaling is associated with the development of PAH, which can be activated by PPI [30](#feb412322-bib-0030){ref-type="ref"}, [31](#feb412322-bib-0031){ref-type="ref"}. Our present results suggested that PPI was a direct target gene of miR‐140‐5p and might mediate miR‐140‐5p regulation of Hippo signaling.

Our predicted network provided potential target genes and relevant signaling pathways that might be modulated by miR‐140‐5p contribution to the development of PAH. Several targets and pathways predicted in our analysis, such as TGF‐betaR1, ADAM10, FGF9, PDGFRA, VEGFA and Notch, PI3K/Akt, TGF‐beta cascades, have been demonstrated to mediate the effects of miR‐140‐5p on antiproliferation and prodifferentiation in several cell types in published studies [16](#feb412322-bib-0016){ref-type="ref"}, [17](#feb412322-bib-0017){ref-type="ref"}, [32](#feb412322-bib-0032){ref-type="ref"}, [33](#feb412322-bib-0033){ref-type="ref"}. While the other targets predicted in our study, including PPI, smad4, JAG1, LAMC1, TLR4, and CREB as well as Hippo signaling pathway, have not been confirmed in the published literature, they still need further verification *in vivo* and *in vitro*.
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